What are Ligand Pharmaceuticals's profit margins?

Gross margin is 91.9% and operating margin is 34.5%, with a 55.9% net margin.

Where does Ligand Pharmaceuticals's income statement data come from?

Every line is extracted from Ligand Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Ligand Pharmaceuticals LGND Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$274.48M+51.2%	$268.09M+60.4%	$251.23M+64.8%	$187.58M+40.5%	$181.49M+53.4%
Research and development	$33.25M-49.3%	$81.18M+279%	$82.1M+265%	$66.75M+199%	$65.54M+175%
General and administrative	$94.48M+9.2%	$92.45M+17.5%	$93.03M+34.7%	$89.06M+50.4%	$86.5M+63.6%
Total costs & expenses	$179.89M-26.1%	$227.09M+19.7%	$233.71M+38.5%	$221.85M+46.0%	$243.3M+103%
Operating income	$94.59M+253%	$41M+281%	$17.52M—	-$34.27M—	-$61.81M—
Operating margin	34.5%+68.5pp	15.3%+28.8pp	7%—	-18.3%—	-34.1%—
Interest expense	$5.6M+48.8%	$4.72M+55.5%	$3.81M+67.2%	$3.64M+136%	$3.76M+575%
Other income (expense), net	$90.3M—	$117.96M—	——	——	——
Income before income taxes	$184.88M—	$158.96M—	——	——	——
Income tax expense	$31.32M—	$34.51M—	——	——	——
Net income	$153.56M+216%	$124.45M+3,187%	$48.58M+7.4%	-$75.86M-280%	-$132.62M-238%
Net margin	55.9%+129pp	46.4%+48.8pp	19.3%-10.3pp	-40.4%-72.0pp	-73.1%-155pp
Diluted earnings per share	$7.43+204%	$5.89+3,045%	$2.03-19.1%	-$4.04-275%	-$7.16-235%
EBITDA	$127.81M+581%	$74.78M+492%	$51.71M+30.0%	$647K-98.4%	-$26.57M-147%
EBITDA margin	46.6%+61.2pp	27.9%+20.3pp	20.6%-5.5pp	0.3%-29.1pp	-14.6%-62.9pp
EBIT	$94.59M+253%	$41M+281%	$17.52M+311%	-$34.27M-917%	-$61.81M-390%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Ligand Pharmaceuticals's profit margins?: Gross margin is 91.9% and operating margin is 34.5%, with a 55.9% net margin.
Where does Ligand Pharmaceuticals's income statement data come from?: Every line is extracted from Ligand Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.